PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.54% | 54.84% | -162.85% | 1,225.51% | -97.78% |
| Total Depreciation and Amortization | -18.18% | 0.00% | -48.84% | -37.68% | -71.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.23% | -59.79% | 152.57% | -716.77% | 96.60% |
| Change in Net Operating Assets | -3.85% | 163.77% | 121.04% | -130.51% | 307.13% |
| Cash from Operations | -73.10% | 23.94% | 25.49% | -1,781.91% | 101.06% |
| Capital Expenditure | -366.67% | 62.50% | -33.33% | -50.00% | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 100.00% |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -366.67% | 62.50% | -33.33% | -50.00% | 99.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 873.03% | 16.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.08% | 2,384.40% | -- | -- |
| Cash from Financing | 100.00% | -100.08% | -19.73% | 840.00% | 16.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.70% | -169.10% | -13.93% | 260.71% | 101.70% |